L.S. van der Schoot, J.J. Janssen, M.T. Bastiaens, A. de Boer-Brand, C. Christiaansen-Smit, D.N.H. Enomoto, . . . E.M.G.J. de Jong. (2023). Steps towards implementation of protocolized dose reduction of adalimumab, etanercept and ustekinumab for psoriasis in daily practice. Taylor & Francis Group.
Chicago Style (17th ed.) CitationL.S. van der Schoot, et al. Steps Towards Implementation of Protocolized Dose Reduction of Adalimumab, Etanercept and Ustekinumab for Psoriasis in Daily Practice. Taylor & Francis Group, 2023.
MLA (9th ed.) CitationL.S. van der Schoot, et al. Steps Towards Implementation of Protocolized Dose Reduction of Adalimumab, Etanercept and Ustekinumab for Psoriasis in Daily Practice. Taylor & Francis Group, 2023.
Warning: These citations may not always be 100% accurate.